ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Nektar Therapeutics

Nektar Therapeutics (NKTR)

1.03
0.00
(0.00%)
Cerrado 19 Noviembre 3:00PM
1.03
0.00
( 0.00% )
Pre Mercado: 3:00AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
1.03
Postura de Compra
0.42
Postura de Venta
1.45
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.4227 Rango de 52 semanas 1.928
Capitalización de Mercado [m]
Precio Anterior
1.03
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,319,927
Acciones en circulación
184,079,479
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.69
Beneficio por acción (BPA)
-1.5
turnover
90.12M
Beneficio neto
-276.06M

Acerca de Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama... Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Nektar Therapeutics is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NKTR. The last closing price for Nektar Therapeutics was US$1.03. Over the last year, Nektar Therapeutics shares have traded in a share price range of US$ 0.4227 to US$ 1.928.

Nektar Therapeutics currently has 184,079,479 shares in issue. The market capitalisation of Nektar Therapeutics is US$189.60 million. Nektar Therapeutics has a price to earnings ratio (PE ratio) of -0.69.

NKTR Últimas noticias

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence PR Newswire SAN FRANCISCO, Nov. 18, 2024...

Nektar Therapeutics Reports Third Quarter 2024 Financial Results

Nektar Therapeutics Reports Third Quarter 2024 Financial Results PR Newswire SAN FRANCISCO, Nov. 7, 2024 SAN FRANCISCO, Nov. 7, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today...

Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.3-22.55639097741.331.3679119814961.10091168CS
4-0.41-28.47222222221.441.47117926071.27147444CS
12-0.2-16.26016260161.231.49113199271.28558625CS
26-0.73-41.47727272731.761.77113451161.29927063CS
520.55114.5833333330.481.9280.422716080181.13235107CS
156-10.82-91.308016877611.8515.9450.412628342482.81140048CS
260-17.29-94.377729257618.32290.412621948596.69236517CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
KITTNauticus Robotics Inc
US$ 1.53
(68.09%)
12.22M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.2633
(61.83%)
35.72M
FFNWFirst Financial Northwest Inc
US$ 30.99
(39.28%)
37
TVGNTevogen Bio Holdings Inc
US$ 1.89
(38.97%)
2.59M
DBGIDigital Brands Group Inc
US$ 0.1615
(38.51%)
20.1M
WSBFWaterstone Financial Inc
US$ 10.12
(-33.64%)
1
PFCPremier Financial Corporation
US$ 20.00
(-27.64%)
100
PRFXPainReform Ltd
US$ 1.05
(-25.00%)
489.25k
XTKGX3 Holdings Company Ltd
US$ 0.11
(-24.09%)
84.67k
MPBMid Penn Bancorp Inc
US$ 25.25
(-19.92%)
103
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.2633
(61.83%)
35.72M
DBGIDigital Brands Group Inc
US$ 0.1615
(38.51%)
20.1M
KITTNauticus Robotics Inc
US$ 1.53
(68.09%)
12.22M
XXII22nd Century Group Inc
US$ 0.104
(6.67%)
9.12M
ELABElevai Labs Inc
US$ 0.0213
(0.00%)
3.8M

NKTR Discussion

Ver más
MB1972 MB1972 3 meses hace
Any news? why the jump? anybody...
👍️0
glenn1919 glenn1919 3 meses hace
NKTR......................................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 meses hace
NKTR..............................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 meses hace
NKTR..............................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 meses hace
NKTR....................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 6 meses hace
NKTR...READY TO BREAK OUT!
👍️0
glenn1919 glenn1919 6 meses hace
NKTR............................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 meses hace
NKTR.........................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 meses hace
NKTR new 52 week high
👍️0
Monksdream Monksdream 7 meses hace
NKTR under $2
👍️0
glenn1919 glenn1919 7 meses hace
NKTR......................................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 meses hace
NKTR new 52 hi
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
NKTR here we go. Every time I go higher with my bench press this stocks follows
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
NKTR setting up here
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
NKTR...MASSIVE VOLUME
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
NKTR...PUSHING TO THE TOP OF THE WEEKLY CLOUD....WILL SHE BREAK FOR BLUE SKY!!!
👍️0
glenn1919 glenn1919 7 meses hace
NKTR........................................................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 meses hace
NKTR new 52 hi
👍️0
Monksdream Monksdream 8 meses hace
NKTR new 52 hi
👍️0
glenn1919 glenn1919 8 meses hace
NKTR..............................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 9 meses hace
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
👍️0
glenn1919 glenn1919 9 meses hace
NKTR.......................................https://stockcharts.com/h-sc/ui?s=NKTR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 meses hace
NKTR 10Q March 4
👍️0
Monksdream Monksdream 1 año hace
NKTR new 52 week low
👍️0
Monksdream Monksdream 1 año hace
NKTR new 52 week low
👍️0
seve333 seve333 1 año hace
Stock is in the toilet again they need an actual settlement from LLY go get the stock moving and so far crickets.
👍️0
sc00pnDump sc00pnDump 1 año hace
Nice stock options 0.68 @ 85,000 shares
👍️0
81vette 81vette 1 año hace
Holding up amazingly well,might continue up
👍️0
Invest-in-America Invest-in-America 1 año hace
NKTR: Now suing Eli Lilly, in conjunction with today's earlier (Dermatitis) news package.
👍️0
Invest-in-America Invest-in-America 1 año hace
NKTR: This one ain't over until the FAT PHARMACISTS sing!!
👍️0
Invest-in-America Invest-in-America 1 año hace
NKTR: Huge numbers of Peeps MISSED your brilliant pick here today, Dude!!! (Talk about 'easy money'!!)
👍️0
AJ Freely AJ Freely 1 año hace
$NKTR - 👆Up 15.8% Pre-Market/ Current Price $0.61
Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in '22 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company
👍️0
The Night Stalker The Night Stalker 1 año hace
cheap
👍️0
The Night Stalker The Night Stalker 1 año hace
cheap
👍️0
DavidTrader DavidTrader 2 años hace
pincher chart on the daily and weekly, I think this could easily run to $1.50
👍️0
Lilman72003 Lilman72003 2 años hace
Hmmm just crickets around here, I don’t mind arriving early to the party
👍️0
DewDiligence DewDiligence 3 años hace
NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures in RCC and bladder cancer:

https://finance.yahoo.com/news/nektar-bristol-myers-squibb-announce-203000621.html Nektar Therapeutics and Bristol Myers Squibb (NYSE: BMY) today announced that based on results from pre-planned analyses of two late-stage clinical studies of bempegaldesleukin (BEMPEG) in combination with Opdivo (nivolumab) in renal cell carcinoma (RCC) and bladder cancer, the companies have jointly decided to end the global clinical development program for bempegaldesleukin in combination with Opdivo. These studies and all other ongoing studies in the program will be discontinued. Bempeg previously failed in a phase-3 trial in combination with Opdivo in melanoma (#msg-168191364), so today’s news is three strikes and you’re out!

Rarely has a cancer drug failed so utterly and completely to live up to initial expectations (#msg-138532013). NKTR’s share price is down 96%(!) from its 2018 high.
👍️0
Frankestin Frankestin 3 años hace
Ouch Ouch
how it hurts here!
I don't even see a reason to hope it goes up!
How much cash do they have?
But that's enough until the end of 2024 if that's okay ...
THE MANAGER OF NEKTAR THERAPEUTICS SAYS TO PREPARE A PLAN THAT HAS THE OBJECTIVE OF ESTABLISHING THE MINIMUM CASH TRACK UNTIL AT LEAST 2024 - CONF. CALL
As the drug fails to meet any of its goals, Nektar said he would consider curbing his cash spending, which was about $ 800 million at the end of December.


Last week, brokerage agency Oppenheimer estimated that worldwide un-risk-adjusted bempegaldesleukin sales could reach $ 3.7 billion in 2038. (news)

I know of one recently approved that will do 3B by 2026
👍️0
DewDiligence DewDiligence 3 años hace
NKTR’s Bempeg fails as addend to Opdivo in first-line melanoma:

https://finance.yahoo.com/news/bristol-myers-squibb-nektar-announce-105900961.html Bristol Myers Squibb and Nektar Therapeutics today announced an update following the first analysis of the Phase 3 PIVOT IO-001 study evaluating the doublet therapy of bempegaldesleukin in combination with Opdivo (nivolumab) compared to Opdivo monotherapy as a first-line treatment for previously untreated unresectable or metastatic melanoma. Following a review of the study for efficacy and safety by an independent Data Monitoring Committee (DMC), Bristol Myers Squibb and Nektar were informed that the study did not meet the primary endpoints of progression-free survival (PFS) and objective response rate (ORR) as assessed by Blinded Independent Central Review (BICR). The DMC notified the companies that the third primary endpoint of overall survival (OS) did not meet statistical significance at the first interim analysis.

Given there was no additional clinical benefit in the doublet therapy arm compared to the monotherapy arm for the primary endpoints of PFS and ORR, and based on the data reviewed by the DMC, the companies have decided to unblind the trial and to perform no additional analyses for the OS endpoint.

Additionally, based on the results from PIVOT IO-001, the companies have also made the decision to discontinue enrollment and unblind the ongoing PIVOT-12 study in adjuvant melanoma, which is evaluating the doublet therapy of bempegaldesleukin in combination with Opdivo compared to Opdivo monotherapy in patients at high risk for recurrence after complete resection of melanoma.
👍️0
DewDiligence DewDiligence 4 años hace
NKTR +18% on clinical-trial_collaboration_testing Bempeg+Keytruda in_H&N_cancer:

https://finance.yahoo.com/news/nektar-announces-agreement-phase-2-130000352.html

NKTR is receiving no cash from MRK—only free drug for use in the trial. Rather, unding for the trial is being provided by NKTR’s financing deal with SJC Pharma (https://finance.yahoo.com/news/nektar-announces-collaboration-sfj-pharmaceuticals-125900283.html ).

Note that the 3-year PD-(L)1 exclusivity period of the BMY/NKTR collaboration, which was announced on 2/14/18, has now expired, enabling NKTR to test Bempeg with any PD-(L)1 agent of its choosing.

p.s. Even after today’s pop, NKTR’s share price is down about 70% from the day of the BMY announcement three years ago.
👍️0
ClayTrader ClayTrader 5 años hace
* * $NKTR Video Chart 01-15-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
DewDiligence DewDiligence 5 años hace
Comments on the JPM webcast: #msg-153299506.
👍️0
DewDiligence DewDiligence 5 años hace
We talk about NKTR a little on #board-1418.
👍️0
Sluicebox Sluicebox 5 años hace
On what board are people discussing Nektar ?
👍️0
czni czni 5 años hace
Yea, bloody taa for !?
I will check back. Those were shot down before I could focus on them. It’s just that one ticker.
A big pharm company is going to buy 11% of a biotech company.
Whatever you do
Find it.
Two day jump could mean over 50% growth before all the old-timers start jumping out because they were holding this in 1912. BC :)
Im an old timer so I can say this.
Dont miss this one!
And please dont let me miss.
I have an entire day on this :(

Once we are free of that, all of the new people will be coming in by Thursday.

Come on people? It’s really important.
👍️0
czni czni 5 años hace
Well if that wasn’t the strangest thing on the planet?

My plan was to research the heck out of this thing and share it with who is on this weekend.

This way we can start Monday ahead of the pac.

There really are only two questions that I would like answers to. This company of course and it’s future and of course what my other message said. Much obliged and whatever I find out, it stays right here.

👍️0
czni czni 5 años hace
I have been doing a lot of studying on this company. I know that we are closer to the 52 week wow than the high. This sector is supposed to be picking up in this company looks pretty decent. What can we expect as far as mergers or stock forecast for 2020? Pretty legitimate not asking for million dollar tickers...

Where are we and where are we going....
👍️0
czni czni 5 años hace
You saw that, yes.
thanks but I do not have a photographic memory unfortunately.

Looks like you were taken down.
Fast!
But we’re smarter than that
👍️0
czni czni 5 años hace
That’s why I love this board. You don’t have to deal with scammers or flippers or anybody trying to feed you a line just to buy end so they can dump. You guys have already been very hospitable. There’s a certain company farmer that is going to buy 11% of a biotech company. If we can find out the ticker symbol on this biotech company,
it’s worth about 180% in the first three days and a bunch more coming after.

Right now the biotech price is very low.

If we can keep it to just us for now The ones here that are interested can get in before the world finds out about it.
Trust me,
I spent four hours digging and digging to find this ticker.

Nobody is leaking it.

Come on guys,
dig a little bit with me.
I promise you it will be worth it!

I put a lot of time in. As soon as I find it I will share on this page. And only this page! It’ll be taken down by Monday so it needs to happen. Everybody takes 15 minutes.

With the experience reading this,
I have no question we can get this ticker symbol.

Monday morning we will be locked and loaded!

Oh yes!
👍️0
czni czni 5 años hace
Hey gang,
Im a quiet holder but have a question driving me crazy!

The MU wait for chips was so Ridiculous even after having this giant to do in Las Vegas.

Do you know the people that paid all around the world to go to Las Vegas just to hear that ticker symbol was not given out at that meeting?

You had to purchase his book in order to get it.

As soon as I dug it up,
I gave it out to everybody.

Now this big Pharma company whoever they are,
are getting ready to purchase 11% of a biotech company.

It has not happened yet but I’m looking for the ticker symbol for the biotech company.

The Pharma company is already out of reach but the biotech company There’s a couple of very important patents making the merger happen quicker.

Does anybody know the biotech company ticker symbol?

I need something that’s going to climb and keep climbing.

On a sidenote,
before my wife finds out I lost just about everything on the stock that should have gone to 50 plus wish i had known they had trouble with their CEO and the CFO having private meetings putting the company under investigation and stopping all Trading for over a month. It trades for 1/10000 of a penny now. I put everything on it!!!

. If you can throw that out to me, you could possibly change my marriage LOL.
Thanks very much and good skill to everyone!
The only job that I have ever had that did not look forward to the weekends!!! Happy hunting!
I dont have pm but please use it if you can. Happy Holidays!

Thanks gang

Sweet Virginia Breeze
👍️0

Su Consulta Reciente

Delayed Upgrade Clock